Patents by Inventor Kenneth A. Witt

Kenneth A. Witt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof
    Patent number: 11912687
    Abstract: The present disclosure describes novel compounds that are somatostatin receptor type 4 agonists.
    Type: Grant
    Filed: September 3, 2021
    Date of Patent: February 27, 2024
    Assignee: Board of Trustees of the Southern Illinois University
    Inventors: Kenneth A. Witt, Albert M. Crider, William Neumann, Audrey Hospital, Karin Sandoval, Maria Kontoyianni
  • 3,4,5-Trisubstituted-1,2,4-Triazoles and 3,4,5-Trisubstituted-3-Thio-1,2,4-Triazoles and Uses Thereof
    Publication number: 20220002274
    Abstract: The present disclosure describes novel compounds that are somatostatin receptor type 4 agonists.
    Type: Application
    Filed: September 3, 2021
    Publication date: January 6, 2022
    Applicant: Board of Trustees of the Southern Illinois University
    Inventors: Kenneth A. Witt, Albert M. Crider, William Neumann, Audrey Hospital, Karin Sandoval, Maria Kontoyianni
  • 3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof
    Patent number: 11136312
    Abstract: The present disclosure describes novel compounds that are somatostatin receptor type 4 agonists.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: October 5, 2021
    Assignee: Board of Trustees of the Southern Illinois University
    Inventors: Kenneth A. Witt, Albert M. Crider, William Neumann, Audrey Hospital, Karin Sandoval, Maria Kontoyianni
  • 3,4,5-Trisubstituted-1,2,4-Triazoles and 3,4,5-Trisubstituted-3-Thio-1,2,4-Triazoles and Uses Thereof
    Publication number: 20200165230
    Abstract: The present disclosure describes novel compounds that are somatostatin receptor type 4 agonists.
    Type: Application
    Filed: May 11, 2018
    Publication date: May 28, 2020
    Inventors: Kenneth A. Witt, Albert M. Crider, William Neumann, Audrey Hospital, Karin Sandoval, Maria Kontoyianni
  • METHODS FOR TREATING MEMORY IMPAIRMENT
    Publication number: 20120283298
    Abstract: Methods for administering a therapeutically effective amount of a somatostatin receptor-4 (SSTR4) agonist in order to treat learning and memory impairment for Alzheimer's disease is disclosed.
    Type: Application
    Filed: October 14, 2010
    Publication date: November 8, 2012
    Inventors: Albert Michael Crider, Kenneth A. Witt, Karin E. Sandoval